Recommendations for identification and public health management of persons with chronic hepatitis B virus infection

Early identification of persons with chronic HBV infection enables infected persons to receive necessary care to prevent or delay onset of liver disease, and enables the identification and vaccination of susceptible household contacts and sex partners, interrupting ongoing transmission. Testing has been recommended previously to enable primary prevention of HBV infection among close contacts for pregnant women, household contacts and sex partners of HBV‐infected persons, persons born in countries with hepatitis B surface antigen (HBsAg) prevalence of more than 8%, persons who are the source of blood or body fluid exposures that might warrant postexposure prophylaxis (e.g., needlestick injury to a healthcare worker or sexual assault), and to enable appropriate treatment for infants born to HBsAg‐positive mothers and persons infected with human immunodeficiency virus. Recently, with the increasing availability of efficacious hepatitis B treatment, the Centers for Disease Control and Prevention published new recommendations for public health evaluation and management for chronically infected persons and their contacts and extended testing recommendations to include persons born in geographic regions with HBsAg prevalence of greater than 2%, men who have sex with men, and injection drug users. Patient and provider education, developing partnerships between health departments and community organizations, and other resources will be needed to assure appropriate populations are tested and care provided for persons newly identified as HBsAg‐positive. (HEPATOLOGY 2009;49:S35–S44.)

[1]  E. Simard,et al.  The prevalence of hepatitis B virus infection in the United States in the era of vaccination. , 2010, The Journal of infectious diseases.

[2]  J. Ward,et al.  Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. , 2008, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[3]  L. Torian,et al.  The Young Men's Survey phase II: hepatitis B immunization and infection among young men who have sex with men. , 2008, American journal of public health.

[4]  M. Sulkowski.  Management of hepatic complications in HIV-infected persons. , 2008, The Journal of infectious diseases.

[5]  J. Hoofnagle,et al.  Systematic Review: The Effect of Preventive Lamivudine on Hepatitis B Reactivation during Chemotherapy , 2008, Annals of Internal Medicine.

[6]  P. Boyle,et al.  Curbing the liver cancer epidemic in Africa , 2008, The Lancet.

[7]  P. van Damme,et al.  Hepatitis A and B vaccination and public health , 2007, Journal of viral hepatitis.

[8]  T. Vogt.  Hepatitis B mortality in the United States, 1990-2004 , 2007 .

[9]  A. Wasley.  Hepatitis B Prevalence in the U.S. in era of vaccination , 2007 .

[10]  M. Brandeau,et al.  Cost-Effectiveness of Screening and Vaccinating Asian and Pacific Islander Adults for Hepatitis B , 2007, Annals of Internal Medicine.

[11]  S. Saab,et al.  Hepatitis B prophylaxis in patients undergoing chemotherapy for lymphoma: A decision analysis model , 2007, Hepatology.

[12]  E. Chang,et al.  Why we should routinely screen Asian American adults for hepatitis B: A cross‐sectional study of Asians in California , 2007, Hepatology.

[13]  A. Caughey,et al.  First- and Second-Trimester Evaluation of Risk for Down Syndrome , 2007, Obstetrics and gynecology.

[14]  B. McMahon,et al.  Corrections to AASLD guidelines on chronic hepatitis B , 2007 .

[15]  E. Chang,et al.  The burden of liver cancer in Asians and Pacific Islanders in the Greater San Francisco Bay Area, 1990 through 2004 , 2007, Cancer.

[16]  T. Madani.  Trend in incidence of hepatitis B virus infection during a decade of universal childhood hepatitis B vaccination in Saudi Arabia. , 2007, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[17]  L. Finelli,et al.  Hepatitis B Virus Infection: Epidemiology and Vaccination , 2006 .

[18]  Tung T. Nguyen,et al.  Health Care Access and Sociodemographic Factors Associated with Hepatitis B Testing in Vietnamese American Men , 2006, Journal of Immigrant and Minority Health.

[19]  A Comprehensive Immunization Strategy to Eliminate Transmission of Hepatitis B Virus Infection in the United States , 2006, Pediatrics.

[20]  B. Bell,et al.  Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). , 2006, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[21]  G. Cunningham,et al.  Economic Evaluation of Tandem Mass Spectrometry Screening in California , 2006, Pediatrics.

[22]  B. McGovern,et al.  The Epidemiology, Natural History and Prevention of Hepatitis B: Implications of HIV Coinfection , 2006, Antiviral therapy.

[23]  L. Finelli,et al.  Surveillance Programs for Chronic Viral Hepatitis in Three Health Departments , 2006, Public health reports.

[24]  H. Margolis,et al.  A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents. , 2005, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[25]  Fangjun Zhou,et al.  A mathematical model to estimate global hepatitis B disease burden and vaccination impact. , 2005, International journal of epidemiology.

[26]  J. Sheffield,et al.  Prevalence of hepatitis B and C in pregnant women who are infected with human immunodeficiency virus. , 2005, American journal of obstetrics and gynecology.

[27]  B. Bell,et al.  Risk factors for hepatitis B in an outbreak of hepatitis B and D among injection drug users , 2005, Journal of Urban Health.

[28]  A. Santra,et al.  Hepatitis B infection in Eastern Indian families: need for screening of adult siblings and mothers of adult index cases. , 2005, Public health.

[29]  Y. Liaw,et al.  Asian‐Pacific consensus statement on the management of chronic hepatitis B: a 2005 update , 2005, Liver international : official journal of the International Association for the Study of the Liver.

[30]  A. Mocroft,et al.  Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort , 2005, AIDS.

[31]  Milton C Weinstein,et al.  Expanded screening for HIV in the United States--an analysis of cost-effectiveness. , 2005, The New England journal of medicine.

[32]  A. Wohl,et al.  Survival in patients with HIV infection and viral hepatitis B or C: a cohort study , 2004, AIDS.

[33]  V. Stone,et al.  Primary care guidelines for the management of persons infected with human immunodeficiency virus: 2009 update by the HIV medicine Association of the Infectious Diseases Society of America. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[34]  A. McNaghten,et al.  Prevalence of chronic hepatitis B and incidence of acute hepatitis B infection in human immunodeficiency virus-infected subjects. , 2003, The Journal of infectious diseases.

[35]  M. Neff.  CDC updates guidelines for prevention and control of infections with hepatitis viruses in correctional settings. , 2003, American family physician.

[36]  H. Margolis,et al.  Prevention and control of infections with hepatitis viruses in correctional settings. Centers for Disease Control and Prevention. , 2003, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[37]  H. Margolis,et al.  Prevention and control of infections with hepatitis viruses in correctional settings. Centers for Disease Control and Prevention. , 2003, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[38]  J. Phair,et al.  HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS) , 2002, The Lancet.

[39]  R. Keren,et al.  Projected cost-effectiveness of statewide universal newborn hearing screening. , 2002, Pediatrics.

[40]  Y. Yasui,et al.  Hepatitis B Knowledge and Practices Among Cambodian American Women in Seattle, Washington , 2002, Journal of Community Health.

[41]  B. McMahon,et al.  Chronic hepatitis B , 2001, Hepatology.

[42]  P. O’Connor,et al.  Screening for diabetes mellitus in high-risk patients: cost, yield, and acceptability. , 2001, Effective clinical practice : ECP.

[43]  P. Venter,et al.  The first five years of universal hepatitis B vaccination in South Africa: evidence for elimination of HBsAg carriage in under 5-year-olds. , 2001, Vaccine.

[44]  R. Janssen,et al.  Two decades after vaccine license: hepatitis B immunization and infection among young men who have sex with men. , 2001, American journal of public health.

[45]  M. Alter,et al.  Recommendations for preventing transmission of infections among chronic hemodialysis patients. , 2001, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[46]  P. Kerndt,et al.  Prevalence of HIV and hepatitis B and self-reported injection risk behavior during detention among street-recruited injection drug users in Los Angeles County, 1994-1996. , 2001, Addiction.

[47]  N. Weiss,et al.  Syringe exchange and risk of infection with hepatitis B and C viruses. , 1999, American journal of epidemiology.

[48]  K. Chayama,et al.  Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: a prospective observation of 2215 patients. , 1998, Journal of hepatology.

[49]  T. Heeren,et al.  HIV and hepatitis B infection and risk behavior in young gay and bisexual men. , 1997, Public health reports.

[50]  T. Farley,et al.  Continuing risk for hepatitis B virus transmission among Southeast Asian infants in Louisiana. , 1995, Pediatrics.

[51]  G Karthikeyan,et al.  Hepatitis B vaccine , 1992 .

[52]  G. Dusheiko,et al.  Management of hepatocellular carcinoma. , 1992, Journal of hepatology.

[53]  J. P. Davis,et al.  Horizontal transmission of hepatitis B virus infection to United States-born children of Hmong refugees. , 1992, Pediatrics.

[54]  S. Hadler,et al.  Outcome of hepatitis B virus infection in homosexual men and its relation to prior human immunodeficiency virus infection. , 1991, The Journal of infectious diseases.

[55]  C. Berg,et al.  Hepatitis B virus infection among children born in the United States to Southeast Asian refugees. , 1989 .

[56]  D. Craven,et al.  Seroprevalence of hepatitis B virus and delta agent in parenteral drug abusers. Immunogenicity of hepatitis B vaccine. , 1986, The American journal of medicine.

[57]  H. Alter,et al.  Landmark article Feb 15, 1965: A "new" antigen in leukemia sera. By Baruch S. Blumberg, Harvey J. Alter, and Sam Visnich. , 1984, JAMA.

[58]  J. Quinn.  Inactivated hepatitis B virus vaccine , 1983 .

[59]  R. Sampliner,et al.  Hepatitis B infection in households of chronic carriers of hepatitis B surface antigen: factors associated with prevalence of infection. , 1982, American journal of epidemiology.

[60]  S. Hadler,et al.  Hepatitis B in homosexual men: prevalence of infection and factors related to transmission. , 1982, The Journal of infectious diseases.

[61]  K. Okuda,et al.  The effect of chronic habitual alcohol intake on the development of liver cirrhosis and hepatocellular carcinoma: Relation to hepatitis B surface antigen carriage , 1982, Cancer.

[62]  G. Raimondo,et al.  MULTICENTRE STUDY OF PREVALENCE OF HBV-ASSOCIATED DELTA INFECTION AND LIVER DISEASE IN DRUG-ADDICTS , 1982, The Lancet.

[63]  M. Conrad,et al.  Hepatitis B antigen and antibody in heroin users. , 1979, The American journal of gastroenterology.

[64]  K. Holmes,et al.  Hepatitis B surface antigen (HBsAg) and antibody to HBsAg. Prevalence in homosexual and heterosexual men. , 1977, JAMA.

[65]  R. Purcell,et al.  The natural history of liver disease in former drug users , 1976, The American journal of the medical sciences.

[66]  J. Hoofnagle,et al.  Antibody against the hepatitis type B core antigen. A new tool for epidemiologic studies. , 1976, American journal of epidemiology.

[67]  S. Hanson,et al.  Liver tests, HB-Ag and HB-Ab in asymptomatic drug addicts. , 1976, The American journal of gastroenterology.

[68]  F. Scheler,et al.  CLOFIBRATE-INDUCED MYOPATHY SYNDROME , 1976, The Lancet.

[69]  J. Hoofnagle,et al.  On the role of sexual behavior in the spread of hepatitis B infection. , 1975, Annals of internal medicine.

[70]  E. Schiff,et al.  Hepatic disease in asymptomatic parenteral narcotic drug abusers: a Veterans Administration collaborative study. , 1975, The American journal of the medical sciences.

[71]  E. Streiff,et al.  "Hippie" hepatitis: an epidemiologic investigation conducted within a population of "street-people". , 1975, American journal of epidemiology.

[72]  R. Chaudhary,et al.  Hepatitis B surface antigen and its subtypes in an institution for the mentally retarded. , 1975, Canadian Medical Association journal.

[73]  B. Berris,et al.  Prevalence and significance of hepatitis B surface antigen in a general hospital. , 1975, Canadian Medical Association journal.

[74]  S. Sherlock,et al.  Role of hepatitis-B antigen carriers in non-parenteral transmission of the hepatitis-B virus. , 1974, Lancet.

[75]  W. Bancroft,et al.  Hepatitis B antigen and antibody. Occurrence in families of asymptomatic HB AG carriers. , 1974, JAMA.

[76]  R. Purcell,et al.  Posttransfusion hepatitis after exclusion of commercial and hepatitis-B antigen-positive donors. , 1972, Annals of internal medicine.

[77]  Wilson Jm,et al.  Principles and practice of mass screening for disease , 1968 .

[78]  H. Alter,et al.  A "NEW" ANTIGEN IN LEUKEMIA SERA. , 1965, JAMA.

[79]  A. Wasley,et al.  Surveillance for acute viral hepatitis--United States, 2006. , 2008, Morbidity and mortality weekly report. Surveillance summaries.

[80]  J. Gerberding,et al.  Screening for chronic hepatitis B among Asian/Pacific Islander populations--New York City, 2005. , 2006, MMWR. Morbidity and mortality weekly report.

[81]  M. Alter,et al.  Epidemiology of viral hepatitis and HIV co-infection. , 2006, Journal of hepatology.

[82]  M. Alter,et al.  A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults. , 2006, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[83]  Acute hepatitis B among children and adolescents--United States, 1990-2002. , 2004, MMWR. Morbidity and mortality weekly report.

[84]  V. Stone,et al.  Primary care guidelines for the management of persons infected with human immunodeficiency virus: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[85]  E. Jury.  EASL International Consensus Conference on Hepatitis B. 13-14 September, 2002: Geneva, Switzerland. Consensus statement (short version). , 2003, Journal of hepatology.

[86]  E. Jury.  EASL International Consensus Conference on Hepatitis B. 13-14 September, 2002 Geneva, Switzerland. Consensus statement (long version). , 2003 .

[87]  S. Acharya,et al.  Epidemiology of hepatitis B virus infection in India. , 1996, Gut.

[88]  N. Flynn,et al.  Seroepidemiology of viral infections among intravenous drug users in northern California. , 1992, The Western journal of medicine.

[89]  Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Committee (ACIP). , 1991, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[90]  Protection against viral hepatitis. Recommendations of the Immunization Practices Advisory Committee (ACIP). , 1990, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[91]  Ja Wilson,et al.  Principles and practice of screening for disease , 1968 .